KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to -$2.2 billion.

  • Ionis Pharmaceuticals' Enterprise Value rose 978.97% to -$2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 billion, marking a year-over-year increase of 978.97%. This contributed to the annual value of -$2.3 billion for FY2024, which is 143.9% up from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Enterprise Value is -$2.2 billion, which was up 978.97% from -$2.3 billion recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Enterprise Value peaked at -$1.8 billion during Q1 2021, and registered a low of -$2.5 billion during Q3 2024.
  • In the last 5 years, Ionis Pharmaceuticals' Enterprise Value had a median value of -$2.1 billion in 2025 and averaged -$2.2 billion.
  • In the last 5 years, Ionis Pharmaceuticals' Enterprise Value surged by 1628.03% in 2021 and then tumbled by 1798.18% in 2023.
  • Ionis Pharmaceuticals' Enterprise Value (Quarter) stood at -$2.1 billion in 2021, then grew by 6.06% to -$2.0 billion in 2022, then dropped by 17.33% to -$2.3 billion in 2023, then grew by 1.44% to -$2.3 billion in 2024, then increased by 2.5% to -$2.2 billion in 2025.
  • Its Enterprise Value stands at -$2.2 billion for Q3 2025, versus -$2.3 billion for Q2 2025 and -$2.1 billion for Q1 2025.